HPV Prevalence among Mexican Women with Neoplastic and Normal Cervixes

By Torroella-Kouri M.   Morsberger S.   Carrillo A.   Mohar A.   Meneses A.   Ibarra M.   Daniel R.W.   Ghaffari A.M.   Solorza G.   Shah K.V.  

Gynecologic Oncology, Vol. 70, Iss. 1, 1998-07 ,pp. : 115-120

Elsevier

Access to resources Recommend Favorite

Cervicography and HPV DNA Testing as Triage Criteria for Patients with Abnormal Pap Smear

By Costa S.   Sideri M.   Bucchi L.   Schettino F.   Maini I.   Spinaci L.   Bovicelli L.   Terzano P.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 404-409

Elsevier

Access to resources Recommend Favorite

HPV Status of Oropharyngeal Cancer by Combination HPV DNA/p16 Testing: Biological Relevance of Discordant Results

By Hong Angela   Jones Deanna   Chatfield Mark   Soon Lee C.   Zhang Mei   Clark Jonathan   Elliott Michael   Harnett Gerald   Milross Christopher   Rose Barbara  

Annals of Surgical Oncology, Vol. 20, Iss. 3, 2013-12 ,pp. : 450-458

Springer Publishing Company

Access to resources Recommend Favorite

Clinical and Economic Implications of Adding HPV Tests to the Routine Cytology Follow-Up and Management of Patients with Histologically Defined Cervical Intraepithelial Neoplasia Grade 1

By Gamzu R.   Almog B.   Levin I.   Fainaru O.   Niv J.   Lessing J.B.   Bar-Am A.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 129-133

Academic Press

Access to resources Recommend Favorite

HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico

By Flores Yvonne  

Cancer Causes and Control, Vol. 22, Iss. 2, 2011-02 ,pp. : 261-272

Springer Publishing Company

Access to resources Recommend Favorite